We showed that the expression of ANAPC1 is reduced in the bone and muscle tissue of osteoporosis patients and that ANAPC1 influences the processes of osteogenic differentiation of the human osteosarcoma cell line by downregulating RUNX2 during osteogenic differentiation. Here, RUNX2 is linked to osteosarcoma.